1 month Terns Pharmaceuticals: Another Potential GLP-1 EntrantSeeking Alpha Terns Pharmaceuticals: Another Potential GLP-1 Entrant. Pharmaceuticals X
1 hour Ligand Pharmaceuticals: Buy This Strong Growing Pharma And Get A Stake In Dozens Of TherapiesSeeking Alpha X
21 hours Regeneron Pharmaceuticals, Inc. (REGN): Among the Most Promising Cancer Stocks According to Hedge FundsInsider Monkey X
2 days Avadel Pharmaceuticals: Despite My Sympathies For The Company, Stock Looks RiskySeeking Alpha X
2 days Goldman Sachs: Vertex Pharmaceuticals Incorporated (VRTX) Is A Top Growth Investor StockInsider Monkey X
3 days Why Is Ionis Pharmaceuticals, Inc. (IONS) Among the Worst Performing Biotech Stocks in 2024?Insider Monkey X
3 days Why Is Madrigal Pharmaceuticals, Inc. (MDGL) Among the Worst Performing Biotech Stocks in 2024?Insider Monkey X
4 days Acurx to add up to $1 million in bitcoin for treasury reserve, following MicroStrategy’s playbookCNBC X
5 days Regeneron Pharmaceuticals, Inc. (REGN) Jefferies London Healthcare Conference (Transcript)Seeking Alpha X
5 days Vertex Pharmaceuticals Incorporated (VRTX) Presents at Stifel 2024 Healthcare Conference (Transcript)Seeking Alpha X
5 days Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should KnowZacks X
5 days Silver Ring Value Partners: Jazz Pharmaceuticals (JAZZ) Is a “High Uncertainty With Low Risk” InvestmentInsider Monkey X
5 days Zacks.com featured highlights Rigel, Synchrony Financial, SkyWest, Allient and Rush Street InteractiveZacks X
6 days Wall Street Analysts Believe Tarsus Pharmaceuticals (TARS) Could Rally 41.09%: Here’s is How to TradeZacks X
6 days Here’s Why Ionis Pharmaceuticals (IONS) is Poised for a Turnaround After Losing -13.46% in 4 WeeksZacks X